Management of Localized Prostate Cancer: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 390: | Line 390: | ||
** The risk of disease reclassification continues over time while on surveillance, likely a result of both undersampling and true histologic disease progression in either tumor grade or volume. | ** The risk of disease reclassification continues over time while on surveillance, likely a result of both undersampling and true histologic disease progression in either tumor grade or volume. | ||
===== | ===== Imaging ===== | ||
* '''mpMRI has been reported to have high sensitivity and specificity for high-grade prostate cancers and thus could be of value in reducing disease misclassification and selecting and monitoring individuals interested in active surveillance''' | * '''mpMRI has been reported to have high sensitivity and specificity for high-grade prostate cancers and thus could be of value in reducing disease misclassification and selecting and monitoring individuals interested in active surveillance''' | ||
** '''<span style="color:#ff00ff">ASIST (2019)</span>''' | ** '''<span style="color:#ff00ff">ASIST (2019)</span>''' | ||